APIDRA SOLOSTAR
Solution for injection in pre-filled pen, 100j./ml
RxActive license
Active substance (INN)
insulin glulisine
Pharmaceutical form
Pharmaceutical formSolution for injection in pre-filled pen
Strength100j./ml
PackagingUkupno 5 napunjenih injekcionih penova sa po 3ml rastvora za injekciju u kartonskoj kutiji
ManufacturerSanofi-Aventis Deutschland GmbH, Germany
Therapeutic groupAlimentary tract and metabolism (A10AB06)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateFebruary 16, 2024
Source: CInMED register